Characterization of a new antibody raised against the NH2 terminus of P-glycoprotein

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 5833-5839

  Rao, Prema S ^a   Govindarajan, Rajgopal ^a   Mallya, Kavita B ^a   West, William ^a   Rao, U Subrahmanyeswara ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; GLYCOPROTEIN P ANTIBODY; METHOTREXATE; MITOXANTRONE; NH211 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CHEMOTHERAPY; CHO CELL; DRUG MECHANISM; EVALUATION; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; EPITOPES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEINS; PEPTIDE FRAGMENTS; PROSTATIC NEOPLASMS;

EID: 23844549244     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2182     Document Type: Article

References (22)

1. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
2. Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 1974;83:103-16.
3. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152-62.
4. Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-24.
5. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987;84:265-9.
6. Trock BJ, Leonessa F, Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 1997;89:917-31.
7. Leith CP, Kopecky KJ, Chen IM, et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 1999;94:1086-99.
8. Georges E, Bradley G, Gariepy J, Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci U S A 1990;87:152-6.
9. Rao VV, Anthony DC, Piwnica-Worms D. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase. J Histochem Cytochem 1995;43:1187-92.
10. Druley TE, Stein WD, Roninson IB. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity. Biochemistry 2001;40:4312-22.
11. Mechetner EB, Schott B, Morse BS, et al. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. Proc Natl Acad Sci U S A 1997;94:12908-13.
12. Nagy H, Goda K, Arceci R, Cianfriglia M, Mechetner E, Szabo G Jr. P-glycoprotein conformational changes detected by antibody competition. Eur J Biochem 2001;268:2416-20.
13. Fairchild CR, Moscow JA, O'Brien EE, Cowan KH. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-π. Mol Pharmacol 1990;37:801-9.
14. Govindarajan R, Zhao S, Song XH, et al. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by α-catenin. J Biol Chem 2002;277:50087-97.
15. Rao US. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells. J Biol Chem 1995;270:6686-90.
16. Rao US, Mehdi A, Steimle RE. Expression of amiloride-sensitive sodium channel: a strategy for the coexpression of multimeric membrane protein in Sf9 insect cells. Anal Biochem 2000;286:206-13.
17. Rao US, Steimle RE, Balachandran P. Activation of large conductance sodium channels upon expression of amiloride-sensitive sodium channel in Sf9 insect cells. J Biol Chem 2002;277:4900-5.
18. Nuti SL, Mehdi A, Rao US. Activation of the human P-glycoprotein ATPase by trypsin. Biochemistry 2000;39:3424-32.
19. Ogretmen B, Safa AR. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells. Oncogene 1997;14:499-506.
20. Kawai K, Sakurai M, Sakai T, et al. Demonstration of MDR1 P-glycoprotein isoform expression in benign and malignant human prostate cells by isoform-specific monoclonal antibodies. Cancer Lett 2000;150:147-53.
21. David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. Int J Oncol 2000;17:1077-86.
22. Nuti SL, Rao US. Proteolytic cleavage of the linker region of the human P-glycoprotein modulates its ATPase function. J Biol Chem 2002;277:29417-23.